Abstract

Ferritin is a globular hollow protein that acts as the major iron storage protein across living organisms. The 8 nmdiameter internal cavity of ferritin has been used as a nanoreactor for the synthesis of various metallic nanoparticles different to iron oxides. For this purpose, ferritin is incubated in solution with metallic ions that enter the cavity through its natural channels. Then, these ions are subjected to a reduction step to obtain highly monodisperse metallic nanoparticles, with enhanced stability and biocompatibility provided by the ferritin structure. Potential biomedical applications of ferritin-nanoparticle complex will require the use of human ferritin to provide a safer and low-risk alternative for the delivery of metallic nanoparticles into the body. However, most of the reported protocols for metallic nanoparticles synthesis uses horse spleen ferritin as nanocontainer. Previous studies have acknowledged technical difficulties with recombinant human ferritin during the synthesis of metallic nanoparticles, like protein precipitation, which is translated into low recovery yields. In this study, we tested a novel photochemical reduction method for silver nanoparticle synthesis in human recombinant ferritin and compared it with the traditional chemical reduction method. The results show that photoreduction of silver ions inside ferritin cavity provides a universal method for silver nanoparticle synthesis in both recombinant human ferritin homopolymers (Light and Heavy ferritin). Additionally, we report important parameters that account for the efficiency of the method, such as ferritin recovery yield (similar to 60%) and ferntin-silver nanoparticle yield (34% for H-ferritin and 17% for L-ferritin).